Monaco Asset Management SAM
Source: SEC Form 13F · as of Mar 2026Monaco Asset Management SAM holds 8 biotech & pharma companies tracked by BioSniper, totaling $15.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$15.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Rocket Pharmaceuticals Inc. (RCKT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| RCKTRocket Pharmaceuticals Inc. | 2,058,303 | $7.4M |
| PLRXPLIANT THERAPEUTICS, INC. | 1,938,747 | $2.4M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 30,000 | $1.7M |
| FATEFATE THERAPEUTICS INC | 810,000 | $972K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 225,000 | $790K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 858,122 | $687K |
| PRQRProQR Therapeutics N.V. | 418,803 | $678K |
| QUREuniQure N.V. | 27,500 | $450K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.